Skip to content

Minimally invasive, ultrasound-guided therapy in patients with plantar fasciitis / fasciosis: a randomised study.

Investigating the efficacy of ultrasound-guided multipunction (MP) treatment versus ultrasound-guided corticosteroid infiltration (CI) in patients with plantar fasciitis / fasciosis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12466306
Enrollment
76
Registered
2024-01-23
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis / fasciosis Musculoskeletal Diseases

Interventions

Patients will be randomly selected to be treated with either ultrasound-guided multipunction or ultrasound-guided corticosteroid infiltration. The assignment to one group or another was carried out ac

Sponsors

Universidad de Sevilla
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and over 2. Symptoms compatible with plantar fasciitis 3. Thickening of the plantar fascia greater than 0.4 cm 4. Consenting to participate in the study

Exclusion criteria

Exclusion criteria: 1. Systemic disease 2. Non-podological morpho-functional alterations that could have an impact on the ankle and foot and that could give rise to important clinical discrepancies in the lower limbs, dissymmetries or obvious clinical scoliosis 3. Having received any treatment (medical, orthopedic and /or invasive) in the foot in the last three months 4. Plantar fasciitis associated with another condition such as nerve entrapment 5. Difficulty in understanding the instructions to follow during treatment

Design outcomes

Primary

MeasureTime frame
Change in patient-reported pain measured using the Visual Analog Scale (VAS) to record pain at baseline and 30, 60 and 120 days following the end of treatment

Secondary

MeasureTime frame
1. Change in foot function measured using the Foot Function Index (FFI) at baseline and 30, 60 and 120 days following the end of treatment 2. Plantar fascia thickness measured using ultrasound at baseline and 30, 60 and 120 days following the end of treatment

Countries

Spain

Contacts

Public ContactRuben Montes Salas
rubmonsal@alum.us.es+34652862125

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026